MIRA
Search documents
微软发布医疗时序基座模型：基于4540亿数据预训练，解决不规则采样难题
量子位· 2026-01-24 05:19
Core Viewpoint - The article discusses the introduction of MIRA, a universal base model designed for medical time series data, which addresses the challenges of irregular and heterogeneous medical data, aiming to enhance predictive capabilities in healthcare AI [5][25]. Group 1: Medical AI Landscape - Large Language Models (LLMs) and Computer Vision (CV) are transforming the healthcare industry, enabling AI to interpret CT images and write medical summaries [1]. - A critical missing piece in medical AI is the ability to understand the "dynamic evolution of life," which is essential for capturing the continuous trajectory of vital signs [2][4]. Group 2: Challenges in Medical Time Series Data - Traditional deep learning models rely on idealized assumptions of uniform data sampling, which do not hold true in real-world medical scenarios, particularly in Intensive Care Units (ICUs) where vital signs are recorded at irregular intervals [9][10]. - The characteristics of medical time series data include irregular time intervals, heterogeneous sampling rates, and data missing due to non-standard clinical workflows [12]. Group 3: MIRA Model Introduction - MIRA is built on 454 billion medical data points and aims to overcome the limitations of traditional models by learning physiological dynamic patterns across various scenarios and modalities [5][25]. - MIRA employs two core technologies: Continuous Time Rotational Position Encoding (CT-RoPE) for understanding historical data and Neural ODE for predicting future states [13][18]. Group 4: Experimental Validation - MIRA demonstrates zero-shot transfer capabilities, outperforming some supervised models in out-of-distribution tests, indicating its ability to learn general physiological signal changes [21]. - MIRA shows high robustness in handling sparse data, maintaining performance even with only 30% of observation points, unlike traditional models that rely on interpolation [23][24]. Group 5: Future Implications - The introduction of MIRA marks a significant step towards a "universal base" era in medical AI, allowing hospitals to quickly develop high-precision customized models with minimal local data [25].
X @Changelly
Changelly· 2025-10-11 18:15
anyways, we keep pushing.two new coins this week: $MIRA and $OPEN.you know the drill → https://t.co/sfUxi5vztQnot for UK users ...
X @BitMart
BitMart· 2025-09-30 22:48
Market Trends - $SL @SaseulOfficial continues to lead in search popularity [1] - $PI and $KBC follow $SL in search popularity [1] - $XPL, $BLESS, and $MIRA are emerging as trending coins [1] Cryptocurrency Focus - The report highlights the most searched coins on BitMart exchange during the week of September 22-28 [1] - The report encourages users to trade the listed coins [1]
BREAKING: MoonLake Immunotherapeutics Shares Down Over 85%; Investors Should Contact Block & Leviton to Potentially Recover Losses
Globenewswire· 2025-09-29 14:53
Core Insights - MoonLake Immunotherapeutics' shares dropped over 85% in pre-market trading on September 29 due to disappointing Phase 3 VELA trial results, with one trial failing to meet its primary endpoint and the other showing only modest gains compared to placebo [2] - The Phase 3 data is considered inadequate compared to the previously reported Phase 2 MIRA trial results and is lagging behind competing drugs, raising concerns about the drug's commercial viability [2] - Block & Leviton is investigating potential securities law violations related to MoonLake's public statements about its drug trials [4] Company Overview - MoonLake Immunotherapeutics is a company involved in drug development, specifically in immunotherapeutics [2] - The company had previously highlighted positive results from its Phase 2 MIRA trial, which are now being overshadowed by the Phase 3 results [2] Legal Investigation - Block & Leviton is actively investigating whether MoonLake Immunotherapeutics committed securities law violations and may file actions to recover losses for affected investors [4] - Investors who have lost money on their MoonLake investments are encouraged to contact Block & Leviton for potential recovery options [5] Investor Eligibility - Any investor who purchased common stock of MoonLake Immunotherapeutics and experienced a decline in share value may be eligible to participate in the investigation, regardless of whether they have sold their shares [3] Whistleblower Information - Individuals with non-public information about MoonLake Immunotherapeutics are encouraged to assist in the investigation or report to the Securities Exchange Commission under the whistleblower program, with potential rewards for original information [6]
X @CoinMarketCap
CoinMarketCap· 2025-09-27 21:00
Project Expansion - Seven projects launched during the week, indicating rapid expansion [1] - Projects include Plasma (XPL) for stablecoin payment and Bitlight Labs (LIGHT) for Bitcoin infrastructure [1] - AOP, FROGGIE, BLESS are also included in the recent additions [1] - Mira Network (MIRA) and Hana Network (HANA) are scheduled for a dual launch [1] Competitive Advantage - Quality curation during fear markets demonstrates Alpha's competitive advantage [1] - Alpha's competitive moat is evident over struggling competitors [1]
X @杀破狼 WolfyXBT
杀破狼 WolfyXBT· 2025-09-26 15:54
狼仔链上已经亏麻了，老实回来刷币安 Alpha 了，还是币安 Alpha 好，今天送了我 100 $MIRA ，价值 1105 人民币，22 顿 KFC，我要一直勤劳刷 😭😭😭 https://t.co/z8XNgoXS2K ...